Tetra Bio-Pharma’s has received a positive opinion from the EMA’s Committee for Orphan Medicinal Products on its application for Orphan...
The company's CEO demanded better regulation for industry despite bumper profits
A clinical trial examining the effect of a cannabis-derived treatment on people with type two diabetes has produced encouraging results.
The balance sheet looks good - but the ethics of exporting labour to the impoverished African nation are complex
Cannaray has appointed an ex-JP Morgan executive ahead of a planned public listing.
UK law means majority of hemp crops must be destroyed despite being highly valuable
Medical cannabis company GW Pharmaceuticals has received the most prestigious official award in British business.
Online CBD marketplace Alphagreen has announced it is planning to move into new European markets.
Sunderland-based Rokshaw has had applications validated - but they're the only ones
The Australia-based company has reported record sales of its pharmaceutical products
EMMAC Life Sciences Group has completed the first step to having its CBD brands fully authorised by the European Food Safety Authority (EFSA).
Policymakers are being asked to rethink the UK's approach to cannabis-derived treatments
CBD company Voyager has formally announced it intends to list on the Aquis Stock Exchange after a successful funding round.